Brief: Heidelberg Pharma Expects FY EBIT Between EUR -19 Mln And EUR -22 Mln

Heidelberg Pharma AG

01/10/2024 14:31

Oct 1 (Reuters) - HEIDELBERG PHARMA AG  HPHA.DE :
    * HEIDELBERG PHARMA AG ANNOUNCES UPDATED GUIDANCE
    * HEIDELBERG PHARMA AG - 2024 SALES AND INCOME EXPECTED
BETWEEN
EUR 10 MILLION AND EUR 12 MILLION
    * HEIDELBERG PHARMA AG - OPERATING EXPENSES EXPECTED BETWEEN
EUR
30 MILLION AND EUR 33 MILLION
    * HEIDELBERG PHARMA AG - OPERATING RESULT (EBIT) EXPECTED
BETWEEN
EUR -19 MILLION AND EUR -22 MILLION
    * HEIDELBERG PHARMA AG - MONTHLY CASH CONSUMPTION EXPECTED
BETWEEN
EUR 1.1 MILLION AND EUR 1.4 MILLION
    * HEIDELBERG PHARMA AG - COMPANY'S FINANCING SECURED UNTIL
MID-2025
    * HEIDELBERG PHARMA AG - 2024 CASH REQUIREMENTS EXPECTED
BETWEEN
EUR 13 MILLION AND EUR 16.5 MILLION
    * HEIDELBERG PHARMA AG - EXPECTED USD 75 MILLION PAYMENT
FROM
HEALTHCARE ROYALTY

Source text for Eikon:  ID:nEQ7Fr52ha 
Further company coverage:  HPHA.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))